FABBRI, Leonardo
 Distribuzione geografica
Continente #
NA - Nord America 3.616
EU - Europa 922
AS - Asia 914
OC - Oceania 4
AF - Africa 3
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.463
Nazione #
US - Stati Uniti d'America 3.602
CN - Cina 455
UA - Ucraina 263
SG - Singapore 196
TR - Turchia 172
DE - Germania 165
IT - Italia 122
GB - Regno Unito 107
SE - Svezia 93
FI - Finlandia 68
ID - Indonesia 41
VN - Vietnam 21
PL - Polonia 20
AT - Austria 14
CA - Canada 14
FR - Francia 14
CZ - Repubblica Ceca 12
RU - Federazione Russa 12
IN - India 6
BE - Belgio 5
LT - Lituania 5
RO - Romania 5
IR - Iran 4
KR - Corea 4
NL - Olanda 4
PT - Portogallo 4
TW - Taiwan 4
AU - Australia 3
IE - Irlanda 3
KE - Kenya 3
BD - Bangladesh 2
JP - Giappone 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BR - Brasile 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
GR - Grecia 1
HK - Hong Kong 1
IL - Israele 1
MK - Macedonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
VE - Venezuela 1
Totale 5.463
Città #
Fairfield 469
Woodbridge 414
Jacksonville 274
Houston 263
Chandler 246
Ashburn 204
Santa Clara 185
Cambridge 172
Wilmington 169
Ann Arbor 150
Seattle 150
Singapore 147
Izmir 123
Beijing 92
Nanjing 92
Princeton 87
Shanghai 44
Jakarta 40
Milan 38
San Diego 38
New York 37
Boardman 33
Addison 32
Tianjin 30
Los Angeles 29
Hebei 28
Nanchang 26
Shenyang 23
Jiaxing 21
Bremen 20
Dong Ket 20
Warsaw 20
Changsha 17
Helsinki 17
Norwalk 16
San Mateo 15
Vienna 14
Munich 13
Washington 13
Dearborn 12
Redwood City 11
Brno 10
Council Bluffs 10
Ferrara 10
London 10
Guangzhou 9
Mountain View 9
Ningbo 9
Jinan 8
Philadelphia 8
Taizhou 8
Falls Church 7
Frankfurt am Main 7
Monmouth Junction 7
Zhengzhou 7
Krasnodar 6
Kunming 6
Orange 6
Augusta 5
Brussels 5
Lanzhou 5
Toronto 5
Beauharnois 4
Delebio 4
Hangzhou 4
Hefei 4
Leawood 4
Rome 4
Dallas 3
Genoa 3
Kilburn 3
Nairobi 3
Ottawa 3
Seoul 3
Verona 3
Amadora 2
Chicago 2
Des Moines 2
Dublin 2
Düsseldorf 2
Edinburgh 2
Favara 2
Fuzhou 2
Las Vegas 2
Modena 2
Olomouc 2
Parma 2
Pavia 2
Potomac 2
Redmond 2
Sona 2
Suri 2
Taipei 2
Tappahannock 2
Walnut 2
Wandsworth 2
Abu Dhabi 1
Amsterdam 1
Andover 1
Ankara 1
Totale 4.092
Nome #
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 138
Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57 127
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 126
Inflammatory cells in the bronchial glands of smokers with chronic bronchitis 125
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease 120
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 118
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation 115
The distribution of Neurokinin-1 and Neurokinin-2 receptors in human central airways 110
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 109
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 108
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 108
Enfisema polmonare: prospettive di terapia 106
Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis 106
Helicobacter pylori and chronic bronchitis. 102
Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure 102
CD-4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjogren's syndrome 99
Integrin expression on neutrophils and mononuclear cells in blood and induced sputum in stable asthma 95
Inhaled corticosteroids in COPD: Friend or foe? 95
Asthma progression and mortality: The role of inhaled corticosteroids 93
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease 92
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC 90
INCREASED BRONCHIAL RESPONSIVENESS IN PRIMARY SJOGRENS-SYNDROME - A SIGN OF TRACHEOBRONCHIAL INVOLVEMENT 89
What can we learn from late-onset and occupational asthma? 87
Increased bronchial responsiveness in primary and secondary Sjogren's syndrome 86
Blood eosinophils for the management of COPD patients? 84
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD 84
Severity of airflow limitation is associated with severity of airway inflammation in smokers 84
Increased xanthine oxidase activity in broncoalveolar lavage fluid from subject with chronic bronchitis 78
Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis 78
Xanthine oxidase in broncho-alveolar lavage fluid of subjects with chronic bronchitis. 76
Inhaled corticosteroid containing combinations and mortality in COPD 75
Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease 75
Oxygen radical production of broncho-alveolar lavage fluid (BALF) from subjects with chronic bronchitis. 74
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal 72
Sonicated serum damages human lymphocyte DNA: a model of free radicals induced cell injury 71
Similarities between mechanism of superoxide production in ultrasuond treated human serum and in BALF from patients with chronic bronchitis 71
Production of superoxide radicals by bronchoalveolar lavage fluid obteined from patients with chronic bronchitis 70
Interleukin-6, but not pentraxin 3, predicts adverse clinical outcomes on short-term prognosis of patients with incipient heart failure 69
Substance P and neurokinin-A in induced sputum from patients with chronic obstructive pulmonary disease. 69
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation 69
Increased oxidant-induced clastogenic activity in bronchoalveolar lavage fluid obtained from subjects with chronic bronchitis. 68
Significant correlation between interleukin-10 expression and progression of non-small cell lung cancer through heme oxygenase 68
Expression of monocyte chemoattractant protein-1 (MCP-1) and CC chemokine receptor 2 (CCR2B) by purified blood monocytes in smokers with lung cancer. 67
Immunization and challenge with toulene diisocyanate decrease tachykinin and calcitonin gene-related peptide immunoreactivity in guinea pig central airways 66
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA 66
Current controversies in chronic obstructive pulmonary disease: A report from the global initiative for chronic obstructive lung disease scientific committee 65
Very low density lipoproteins mediate DNA damage induced by sonicated serum on human lymphocytes. 64
Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations 64
Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study 63
Differential expression of heme oxygenase (HO)-1 in macrophages of lung tumour and tumour-free lung tissues 63
Mucin expression in the bronchiolar epithelium of patients with chronic obstructive pulmonary disease. 62
Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications. 62
Neutrophils and asthma. 61
Altri problemi di patologia respiratoria 61
Mechanism of occupational asthma 60
Human leukocyyte antigen associations in occupational asthma induced by isocyanates 59
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 59
Espression of vasoactive intestinal peptide 1 receptor (VIPR1) in the central airways of smokers 57
Glucocorticoidi 56
Prevention of Chronic Obstructive Pulmonary Disease 56
HLA class II molecules and asthma induced by toleune diisocyanate 55
null 50
Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients 50
Management of chronic refractory cough in adults 50
null 45
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact 44
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal 36
Small airway dysfunction: not so silent after all? 33
Chronic cough in adults 32
Extrafine beclometasone dipropionate/ formoterol fumarate vs double bronchodilation therapy in patients with copd: A historical real-world non-inferiority study 30
COPD is a risk factor for squamous cell histotype in smokers who develop nonsmall cell lung cancer. Eur Resp J 2003; 22 Supp.45: 361s. 27
Spirometry: A practical lifespan predictor of global health and chronic respiratory and non-respiratory diseases 24
Rate of Decline of FEV1 as Biomarker of Survival? 23
Inhaled long-acting muscarinic antagonists in asthma - A narrative review 23
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease 20
Influence of asbestos exposure on heme oxygenase(HO)-1 expression in lung tumour-associated macrophages. 169 (7): A411. 19
Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study 14
Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice 12
Long-term inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease, cardiovascular disease, and a recent hospitalised exacerbation: The ICSLIFE pragmatic, randomised controlled study 8
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS 4
Sex differences in asthma control, lung function and exacerbations: the ATLANTIS study 3
Leveraging Computed Tomography Imaging to Detect Chronic Obstructive Pulmonary Disease and Concomitant Chronic Diseases 3
Totale 5.597
Categoria #
all - tutte 31.708
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 915
Totale 32.623


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020684 0 0 0 0 68 131 86 113 83 89 92 22
2020/2021869 55 82 44 64 37 70 30 100 27 104 138 118
2021/2022766 24 51 46 60 60 25 25 43 36 52 68 276
2022/2023601 73 13 39 76 107 80 35 53 69 3 36 17
2023/2024371 40 45 20 13 24 53 12 24 14 5 10 111
2024/2025523 36 58 150 51 228 0 0 0 0 0 0 0
Totale 5.597